First Manhattan CO Immuneering Corp Transaction History

First Manhattan CO

  • $35.3 Billion
  • Q3 2025

A detailed history of First Manhattan CO transactions in Immuneering Corp stock. As of the latest transaction made, First Manhattan CO holds 24,245 shares of IMRX stock, worth $155,168. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,245
Previous 32,325 25.0%
Holding current value
$155,168
Previous $108,000 46.3%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$3.04 - $9.26 $24,563 - $74,820
-8,080 Reduced 25.0%
24,245 $158,000
Q4 2024

Feb 14, 2025
BUY
$1.62 - $2.47 $52,366 - $79,842
32,325 New
32,325 $71,000
Q2 2024

Aug 13, 2024
BUY
$1.28 - $2.75 $52,480 - $112,750
41,000 Added 123.31%
74,250 $95,000
Q1 2024

May 15, 2024
BUY
$1.91 - $7.32 $63,507 - $243,390
33,250 New
33,250 $96,000

About Immuneering Corp

IMRX Quotes by TradingView
  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $169M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email